Lipidaemic and Hepatic Status of Type 2 Diabetic Rats Treated with the Polyherbal Capsule Glucoblock

Main Article Content

O. N. Briggs
K. N. Elechi-Amadi
F. C. Ezeiruaku
R. E. Teme


The scourge of diabetes has led to an increase in the use of complementary and alternative medicine. The lack of regulation and control leads to the indiscriminate use of these herbals, with potential risk to patients.

Aim: This study evaluates the lipidaemic and hepatic status of type 2 diabetic rats treated with the polyherbal capsule glucoblock.

Methodology: A total of 35 male Wistar albino rats weighing between 120-220 g were used for this study. The rats were placed on high fat diet and diabetes was induced by a single intraperitoneal injection of freshly prepared streptozotocin (STZ) (45 mg/kg body wt). Fasting plasma glucose (FPG) was determined using the glucose oxidase method. Total Cholesterol (TC), Triglyceride (TG) and High Density Lipoprotein Cholesterol (HDL-C) were determined using enzymatic methods. Low Density Lipoprotein Cholesterol (LDL-C) was calculated using the Friedewald’s equation. Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) were determined using Reitman-Frankel method, while alkaline phosphatase (ALP) was determined using the colorimetric phenolphthalein method. Liver sections were stained using haematoxylin and eosin (H&E) staining technique, and phytochemical analysis was also done on the herbal capsule.

Results: The results show no significant differences in TC levels in all groups compared to the negative control. TG level was significantly higher in the diabetic control group when compared to the negative control. TG level in the singular treatment groups were significantly lower, but the combination group (glibenclamide + glucoblock) showed no significant difference compared to the diabetic control. The negative control had significantly higher HDL-C compared to the diabetic control and treatment groups. There were no significant differences in HDL-C levels in all the treatment groups, when compared to the diabetic control. The negative control had significantly lower LDL-C compared to the diabetic control and treatment groups. There were no significant differences in LDL-C levels in all the treatment groups, when compared to the diabetic control. ALT, AST and ALP levels were significantly higher in the diabetic control, but was significantly reduced to normal levels by the treatments. Liver sections of the negative control showed normal histoarchitecture. The diabetic control showed inflammation and fatty deposition. The treatment groups showed a nearly normal histoarchitecture, with fatty deposits.

Conclusion: High fat diet in combination with a sub-diabetic dose of streptozotocin produced significant diabetes in the Wistar rats with dyslipidaemia and elevated liver enzyme levels. The anti-diabetic treatments, glibenclamide and glucoblock did not correct the dyslipidaema caused by diabetes. However, the treatments had equipotent hepatoprotective effect and restored liver enzyme levels to normal as well as improving liver histology.

Diabetes mellitus, dyslipidaemia, lipid profile, liver enzymes, complementary and alternative medicine, phytochemicals, glucoblock, glibenclamide, high fat diet, streptozotocin

Article Details

How to Cite
Briggs, O. N., Elechi-Amadi, K. N., Ezeiruaku, F. C., & Teme, R. E. (2020). Lipidaemic and Hepatic Status of Type 2 Diabetic Rats Treated with the Polyherbal Capsule Glucoblock. Journal of Advances in Medical and Pharmaceutical Sciences, 22(1), 6-15.
Original Research Article


Reaven GM. The role of insulin resistance in human disease. Diabetes. 1998;37: 1595–1607.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38(1):01-93.

International Diabetes Federation. International Diabetes Federation Diabetes Atlas (7th Ed.). International Diabetes Federation; 2016.

Briggs ON, Brown H, Elechi-amadi K, Ezeiruaku F, Nduka N. Superoxide dismutase and glutathione peroxidase levels in patients with long standing type 2 diabetes in Port Harcourt, Rivers State, Nigeria. International Journal of Science and Research. 2016;5(3):1282-1288.

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation Research. 2010;107(9):1058-1070.

Ahmadieh H, Azar ST. Liver disease and diabetes: Association, pathophysiology, and management. Diabetes Research and Clinical Practice. 2014;104(1):53–62.

Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: Implications for atherogenesis and treatment. Clinical Lipidology. 2011;6(4):401-411.

Medagama AB, Bandara R. The use of Complementary and Alternative Medicines (CAMs) in the treatment of diabetes mellitus: Is continued use safe and effective? Nutrition Journal. 2014;13:102.

Matheka DM, Demaio AR. Complementary and alternative medicine use among diabetic patients in Africa: A Kenyan perspective. Pan African Medical Journal. 2013;15(110):1-5.

Organisation for Economic Co-operation and Development. Guidance document on acute oral toxicity testing: Environmental health and safety monograph series on testing and assessment No. 24. 2001;24.
(Accessed 14th July, 2018)

Paget GE, Barnes JM. Evaluation of drug activities. In Lawrence DR, Bacharach AL. (Eds.). Pharmacometrics, New York: Academy Press. 1964;161.

Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC. Single dose streptozotocin induced diabetes: Considerations for study design in islet transplantation models. Lab Animal. 2011; 45(3):131–140.

Breyer MD, Bottinger E, Brosius FC, Coffman TM, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. Journals of the American Society of Nephrology. 2005;16:27-45.

Furman BL. Streptozotocin-induced diabetic models in mice and rats. Current Protocols in Pharmacology. 2015;70(5):1-20.

Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972;97(151):142-145.

Allain CC, Pooon LS, Cicely SGC, Richmond W, Fu PC. Enzymatic determinants of total serum cholesterol. Journal of Clinical Chemistry. 1974;20(4): 470–475.

Tietz NW. A Clinical Guide to Laboratory Tests (2nd Ed.). Philadelphia: WB. Sanders; 1990.

Lopes-Virella MF, Stone P, Colwell J. Cholesterol determination in high density lipoproteins separated by three different methods. Clinical Chemistry. 1977;28:882–884.

Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of LDL cholesterol in plasma without the use of the preparative ultra-centrifugation. Journal of Clinical Chemistry. 1972;18:499 –502.

Reitman S, Frankel S. A colorimetric method for the determination of glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology. 1957;28:56-66.

Klein B, Read PA, Babson LA. Alkaline phosphatase activity measurement. Clinical Chemistry. 1960;6:269-275.

Ezeonu CS, Ejikeme CM. Qualitative and quantitative determination of phyto-chemical contents of indigenous Nigerian softwoods. New Journal of Science. 2016; 2016:5601327.

Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251-286.

Warraich HJ, Wong ND, Rana JS. Role for combination therapy in diabetic dyslipidemia. Current Cardioliology Reports. 2015;17(5):32.

Gupta PP, Haider J, Yadav RP, Pal U. Preclinical evaluation of antidiabetic activity of polyherbal plant extract in streptozotocin induced diabetic rats. The Journal of Phytopharmacology. 2016;5(2): 45-49.

Arshadi S, Azarbayjani MA, Hajiaghaalipour F, Yusof A, Peeri M, Bakhtiyari S, Stannard RS, Osman NAA, Dehghan F. Evaluation of Trigonella foenum-graecum extract in combination with swimming exercise compared to glibenclamide consumption on type 2 diabetic rodents. Food & Nutrition Research. 2015;59:29717.

Gotama TL, Husni A, Ustadi H. Antidiabetic activity of Sargassum hystrix extracts in streptozotocin-induced diabetic rats. Preventive Nutrition and Food Science. 2018;23(3):189–195.

Mishra S, Ahmed QS, Sayedda K. Comparative evaluation of the effect of Ocimum sanctum and metformin on serum lipid profile in high fat diet fed diabetic rats. International Journal of Basic & Clinical Pharmacology. 2019;8:589-594.

Farokhi F, Farkhad NK, Togmechi A, Soltani BK. Preventive effects of Prangos ferulacea (L.) Lindle on liver damage of diabetic rats induced by alloxan. Avicenna Journal of Phytomedicine. 2011;2:63-71.

Salih ND, Kumar GH, Noah RM, Muslih RK. The effect of streptozotocin induced diabetes mellitus on liver activity in mice. Advences in Applied Sciences. 2014;3:67-75.

Briggs ON, Nwachuku EO, Bartimaeus ES, Tamuno-Emine D, Elechi-Amadi KN, Nsirim N. Antidiabetic and antioxidant effects of the polyherbal drug glucoblock and glibenclamide in type 2 diabetic rats. Journal of Advances in Medical and Pharmaceutical Sciences. 2019;21(2):1- 9.

Briggs ON, Nwachuku EO, Brown H, Elechi-Amadi KN. Therapeutic effects of the anti-diabetic polyherbal drug diawell in combination with metformin on liver and lipid parameters in type 2 diabetic rats. Journal of Complementary and Alter- native Medical Research. 2019;8(2):1- 10.

Khajuria P, Raghuwanshi P, Rastogi A, Koul AL, Zargar R, Kour S. Hepatoprotective effect of seabuckthorn leaf extract in streptozotocin induced diabetes mellitus in wistar rats. Indian Journal of Animal Research. 2018;52(12): 1745-1750.

Otunola GA, Afolayan AJ. Antidiabetic effect of combined spices of Allium sativum, Zingiber officinale and Capsicum frutescens in alloxan-induced diabetic rats. Frontiers in Life Science. 2015;8(4): 314-323.

Balamash KS, Alkreathy HM, Al-Gahdali EH, Khoja SO, Ahmad A. Comparative biochemical and histopathological studies on the efficacy of metformin and virgin olive oil against streptozotocin-induced diabetes in sprague-dawley rats. Journal of Diabetes Research. 2018;20:4692197.